KFSHRC's Groundbreaking Study On Robotic Liver Transplantation Recognised As Top Paper Of 2024

The King Faisal Specialist Hospital & Research Centre (KFSHRC) has established itself as a pioneer in medical innovation. Its groundbreaking study on fully robotic liver transplants was honoured as one of the Top 10 Most Impactful Papers of 2024 by the American Society of Transplantation. This recognition highlights KFSHRC's commitment to advancing medical science and improving patient care.

The study, titled "Outcomes of Fully Robotic Recipient Living Donor Liver Transplant about the Open Approach," marks a significant milestone in medical research. It is the first series globally to explore fully robotic recipient liver transplants from living donors. The paper underscores notable improvements in robotic-assisted liver transplantation, such as reduced blood loss, shorter hospital stays, and better cosmetic results compared to traditional open surgery methods.

Importantly, these advancements were achieved without increasing complication rates. This success "reinforces KFSHRC's leadership in setting new surgical innovation and patient care benchmarks," according to the press release. The study's findings demonstrate the potential for robotic surgery to transform high-risk procedures into safer and more efficient operations.

Professor Dr. Dieter Broering, Executive Director of the Organ Transplant Centre of Excellence at KFSHRC, played a pivotal role in this achievement. He is renowned globally for his expertise in robotic-assisted surgeries. Dr. Broering was instrumental in performing the world's first fully robotic left lobe liver transplant in 2024.

Dr. Broering stated, "This achievement highlights the transformative potential of robotic transplant, particularly for procedures previously considered high-risk, and reaffirms our dedication to delivering safer, faster, and more effective outcomes for patients worldwide." His words reflect KFSHRC's ongoing commitment to pushing the boundaries of medical technology.

The study was published in the Transplantation Journal, which serves as an essential platform for pioneering research. With over 58 years of history and more than 25,000 annual citations, this journal is a cornerstone for sharing innovative medical findings with the global community.

KFSHRC's Prestigious Rankings

KFSHRC has consistently been recognised for its excellence in healthcare. It ranked first in the Middle East and Africa and 20th globally among the world's top 250 Academic Medical Centers for two consecutive years. Additionally, it was named the most valuable healthcare brand in Saudi Arabia and the Middle East according to Brand Finance's 2024 rankings.

Furthermore, Newsweek magazine included KFSHRC in its World's Best Smart Hospitals list for 2025. These accolades underscore KFSHRC's dedication to maintaining high standards in healthcare delivery and innovation.

KFSHRC continues to lead in medical advancements while enhancing patient care quality worldwide. Its achievements set new benchmarks for others to follow in both regional and international healthcare landscapes.

With inputs from SPA